Repetition of Prediabetes Enhances the Risk of Developing Diabetes.
Journal
Journal of diabetes research
ISSN: 2314-6753
Titre abrégé: J Diabetes Res
Pays: England
ID NLM: 101605237
Informations de publication
Date de publication:
2019
2019
Historique:
received:
29
11
2018
revised:
03
02
2019
accepted:
26
02
2019
entrez:
18
4
2019
pubmed:
18
4
2019
medline:
23
10
2019
Statut:
epublish
Résumé
We attempted to clarify the severity of the risk of diabetes mellitus (DM) in the individuals who repeatedly fulfill the criteria for prediabetes in both fasting plasma glucose (FPG) and hemoglobin A1c (HbA1c). The subjects were 2347 individuals who underwent annual health checkup at our hospital. They were classified as normal glucose tolerance or prediabetes as their yearly status of glucose tolerance for three years; furthermore, the individuals classified as prediabetes were subclassified into 3 groups. Among them, we focused the individuals who fulfilled the criteria for prediabetes in both FPG and HbA1c, and this group was named as PD3. Similarly, all subjects were categorized into 4 groups by the frequency of the status of PD3 during three years. Moreover, all subjects were categorized into 8 patterns when PD3 status was positive. Then, we surveyed the development of diabetes for 5 years, and the incidence rates (IRs) and the age- and sex-adjusted odds ratios (ORs) were obtained. A total of 188 subjects developed diabetes. The individuals in the group of PD3 showed the highest IR of DM (33.6%). The values of ORs were 11.5, 20.0, and 63.5 when the frequencies of PD3 were one, two, and three, respectively. In the group whose frequency of PD3 was two, the individuals who had repeated the status of PD3 twice then moved to the status other than PD3 showed smaller risk of DM than the others in the same group. In conclusion, individuals who fulfill the criteria for prediabetes in both FPG and HbA1c were at a high risk of developing DM, and the risk was enhanced by repeating this status. On the other hand, changing the status from PD3 to others might reduce the risk of DM.
Identifiants
pubmed: 30993116
doi: 10.1155/2019/4916546
pmc: PMC6434284
doi:
Substances chimiques
Blood Glucose
0
Glycated Hemoglobin A
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
4916546Références
N Engl J Med. 2002 Feb 7;346(6):393-403
pubmed: 11832527
Diabetes Care. 2006 Sep;29(9):2114-6
pubmed: 16936162
Diabetes Res Clin Pract. 2007 Sep;77(3):451-8
pubmed: 17346846
Diabetes Care. 2009 Nov;32 Suppl 2:S373-7
pubmed: 19875584
J Diabetes Sci Technol. 2009 Jul 01;3(4):756-60
pubmed: 20144325
Clin Chem. 2011 Jun;57(6):793-8
pubmed: 21617153
Lancet. 2011 Jul 9;378(9786):147-55
pubmed: 21705064
Diabet Med. 2012 Sep;29(9):e279-85
pubmed: 22510023
Lancet. 2012 Jun 16;379(9833):2279-90
pubmed: 22683128
Diabetes Care. 2013 Aug;36(8):2430-9
pubmed: 23788649
J Gen Intern Med. 2014 Feb;29(2):388-94
pubmed: 24002631
Diabetes Care. 2013 Dec;36(12):3923-9
pubmed: 24135387
Diabetes Care. 2014 Jan;37 Suppl 1:S81-90
pubmed: 24357215
J Diabetes Investig. 2012 Feb 20;3(1):39-40
pubmed: 24843544
World J Diabetes. 2015 Mar 15;6(2):296-303
pubmed: 25789110
J Diabetes Investig. 2016 Mar;7(2):155-65
pubmed: 27042265
Endocr Rev. 2016 Jun;37(3):278-316
pubmed: 27159875
Liver Int. 2016 Nov;36(11):1563-1579
pubmed: 27276701